652 related articles for article (PubMed ID: 14571716)
1. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma.
Lee JC; Chen MJ; Chang CH; Tiai YF; Lin PW; Lai HS; Wang ST
Hepatogastroenterology; 2003; 50(53):1269-73. PubMed ID: 14571716
[TBL] [Abstract][Full Text] [Related]
2. [Alteration of plasma amino acid content in primary liver cancer patients].
Ye AL; Tang ZY; Liu H; Zhao QR; Zhu WN
Zhonghua Zhong Liu Za Zhi; 1987 May; 9(3):190-2. PubMed ID: 2834157
[TBL] [Abstract][Full Text] [Related]
3. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
4. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
[TBL] [Abstract][Full Text] [Related]
5. Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis.
Schulte-Frohlinde E; Wagenpfeil S; Willis J; Lersch C; Eckel F; Schmid R; Schusdziarra V
J Gastroenterol Hepatol; 2007 Aug; 22(8):1241-8. PubMed ID: 17688664
[TBL] [Abstract][Full Text] [Related]
6. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
[TBL] [Abstract][Full Text] [Related]
7. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.
Melia WM; Wilkinson ML; Portmann BC; Johnson PJ; Williams R
Q J Med; 1984; 53(211):391-400. PubMed ID: 6207557
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.
Chang CH; Chau GY; Lui WY; Tsay SH; King KL; Wu CW
Arch Surg; 2004 Mar; 139(3):320-5; discussion 326. PubMed ID: 15006892
[TBL] [Abstract][Full Text] [Related]
10. Oxidative metabolism in cirrhotic patients with and without hepatocellular carcinoma: effects of malnutrition.
Guglielmi FW; Mastronuzzi T; De Marco M; Laddaga L; Panella C; Francavilla A
Hepatology; 1992 Nov; 16(5):1144-9. PubMed ID: 1330866
[TBL] [Abstract][Full Text] [Related]
11. Significance of the molar ratio of branched-chain amino acids to tyrosine before hepatectomy.
Kohashi T; Itamoto T; Katayama K; Katayama S; Hino H; Nakahara H; Tashiro H; Asahara T
Hepatogastroenterology; 2002; 49(45):774-7. PubMed ID: 12063988
[TBL] [Abstract][Full Text] [Related]
12. [Plasma amino acids in patients with liver cirrhosis treated with lactulose].
Giardina MG; Matarazzo M; Prantera T; Verre C; De Marco F
Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2309-16. PubMed ID: 6529509
[TBL] [Abstract][Full Text] [Related]
13. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
Trevisani F; Bernardi M; Arienti V; Scrivano P; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G
Hepatology; 1994 Feb; 19(2):329-38. PubMed ID: 8294090
[TBL] [Abstract][Full Text] [Related]
14. Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis.
Henry L; Lavabre-Bertrand T; Vercambre L; Ramos J; Carillo S; Guiraud I; Pouderoux P; Bismuth M; Valats JC; Demattei C; Duny Y; Chaze I; Funakoshi N; Bureau JP; Daurès JP; Blanc P
Gut; 2009 Jun; 58(6):833-8. PubMed ID: 19201777
[TBL] [Abstract][Full Text] [Related]
15. Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.
Xu J; Shi J; Wang YP; Lin Y; Chen YX; Lu J; Zeng X; Xie WF
Med Sci Monit; 2009 Jun; 15(6):CR274-9. PubMed ID: 19478697
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma.
Doğan UB; Cindoruk M; Dumlu S; Unlü R; Unal S
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):476-7. PubMed ID: 9494860
[No Abstract] [Full Text] [Related]
17. Plasma amino acid patterns in portal hypertensive patients.
Wang MW; Lee XY; Lee H; Sun HK
J Gastroenterol Hepatol; 1989; 4 Suppl 1():259-61. PubMed ID: 2562391
[No Abstract] [Full Text] [Related]
18. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial.
Poon RT; Yu WC; Fan ST; Wong J
Aliment Pharmacol Ther; 2004 Apr; 19(7):779-88. PubMed ID: 15043519
[TBL] [Abstract][Full Text] [Related]
19. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K
Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
[TBL] [Abstract][Full Text] [Related]
20. Increased energy expenditure in cirrhotic patients with hepatocellular carcinoma.
Merli M; Riggio O; Servi R; Zullo A; De Santis A; Attili AF; Capocaccia L
Nutrition; 1992; 8(5):321-5. PubMed ID: 1330106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
